Ottobock SE & Co. KGaA (OBCK) - Net Assets
Based on the latest financial reports, Ottobock SE & Co. KGaA (OBCK) has net assets worth €419.50 Million EUR (≈ $490.44 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€2.08 Billion ≈ $2.43 Billion USD) and total liabilities (€1.66 Billion ≈ $1.94 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible equity quality of Ottobock SE & Co. KGaA to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €419.50 Million |
| % of Total Assets | 20.17% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Ottobock SE & Co. KGaA - Net Assets Trend (2025–2025)
This chart illustrates how Ottobock SE & Co. KGaA's net assets have evolved over time, based on quarterly financial data. See OBCK equity to assets ratio to measure how much of total assets are equity-financed.
Annual Net Assets for Ottobock SE & Co. KGaA (2025–2025)
The table below shows the annual net assets of Ottobock SE & Co. KGaA from 2025 to 2025. For live market cap and overall valuation, see market cap of Ottobock SE & Co. KGaA.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €397.50 Million ≈ $464.72 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Ottobock SE & Co. KGaA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €223.40 Million | 57.27% |
| Other Components | €166.70 Million | 42.73% |
| Total Equity | €390.10 Million | 100.00% |
Ottobock SE & Co. KGaA Competitors by Market Cap
The table below lists competitors of Ottobock SE & Co. KGaA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dave Inc
NASDAQ:DAVE
|
$3.81 Billion |
|
Dolby Laboratories
NYSE:DLB
|
$3.82 Billion |
|
Hafnia Ltd
OL:HAFNI
|
$3.82 Billion |
|
PT Indofood Sukses Makmur Tbk
JK:INDF
|
$3.82 Billion |
|
China Airlines Ltd
TW:2610
|
$3.81 Billion |
|
Yongxing Special Stainless Steel Co Ltd
SHE:002756
|
$3.81 Billion |
|
Constellium SE
F:3OK
|
$3.81 Billion |
|
Atour Lifestyle Holdings Limited American Depositary Shares
NASDAQ:ATAT
|
$3.81 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ottobock SE & Co. KGaA's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Ottobock SE & Co. KGaA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 9.51x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2025-12-31 | €6.10 | €58.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ottobock SE & Co. KGaA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 23.12%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.37%
- • Asset Turnover: 0.82x
- • Equity Multiplier: 5.25x
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2025 | 23.12% | 5.37% | 0.82x | 5.25x | €51.19 Million |
Industry Comparison
This section compares Ottobock SE & Co. KGaA's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $6,158,568,737
- Average return on equity (ROE) among peers: -6.05%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ottobock SE & Co. KGaA (OBCK) | €419.50 Million | 23.12% | 3.96x | $3.81 Billion |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $709.04 Million | 17.68% | 0.69x | $2.39 Billion |
| RENAU.UNSP.ARD 1/5 EO-20 (56S0) | $2.67 Billion | 11.61% | 1.89x | $15.47 Billion |
| MEDIMI AB AK (79T) | $15.25 Million | -101.01% | 0.19x | $365.27K |
| TEVANO SYSTEMS HLDGS INC. (7RBA) | $-1.31 Million | 0.00% | 0.00x | $210.67K |
| STEVANATO GROUP SPA O.N. (87N) | $1.49 Billion | 9.41% | 0.71x | $1.05 Billion |
| Carl Zeiss Meditec AG (AFX) | $754.23 Million | 9.94% | 0.38x | $2.23 Billion |
| CARL ZEISS MEDITEC ADR 1 (AFXA) | $2.13 Billion | 6.64% | 0.60x | $2.14 Billion |
| Bio-gate AG (BIG1) | $3.45 Million | -46.99% | 0.52x | $7.12 Million |
| COLOPLAST SP.ADR 1/10 DK1 (CBH) | $17.94 Billion | 28.16% | 1.68x | $12.73 Billion |
| ESSILORLUXOTTICA 1/2/O.N. (ESLC) | $35.88 Billion | 4.04% | 0.66x | $78.07 Billion |
About Ottobock SE & Co. KGaA
Ottobock SE & Co. KGaA develops, produces, and distributes medical technology products and components for the people with disabilities in the fields of prosthetics, orthotics, human mobility, and industrial exoskeletons in Europe, the Middle East, Africa, North and South America, and the Asia Pacific. The company is involved in identification, development, manufacturing, sales, and marketing of p… Read more